Connect with us

Hi, what are you looking for?

press release

Kessler Topaz Meltzer & Check, LLP reminds investors of November – Press Release

RADNOR, Pa., Nov. 05, 2022 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is notifying investors that a securities class action lawsuit has been filed against Fulgent Genetics, Inc. (“Fulgent”) in the United States District Court for the Central District of California. FLGT. The lawsuit alleges Fulgent’s violations of federal securities laws, including omissions and fraudulent misrepresentations regarding the company’s business, operations and prospects. Fulgent investors have suffered significant losses as a result of Fulgent’s materially misleading public statements and omissions.

CLICK HERE SUBMIT YOUR FULFILLMENT LOSSES. YOU CAN ALSO CLICK OR COPY AND PASTE THE FOLLOWING LINK INTO YOUR BROWSER: https://www.ktmc.com/new-cases/fulgent-genetics-inc?utm_source=PR&utm_medium=link&utm_campaign=fulgent&mktm=r

CAN’T WATCH THIS VIDEO? YOU’RE WELCOME CLICK HERE

LIMIT FOR THE PLAINTIFF: NOVEMBER 21, 2022

COURSE PERIOD: MARCH 22, 2019 TO AUGUST 4, 2022

CONTACT AN ATTORNEY TO DISCUSS YOUR RIGHTS:
Jonathan Naji, Esq. at (484) 270-1453 or email at info@ktmc.com

Kessler Topaz is one of the world’s leading advocates for protecting the public from corporate fraud and other wrongdoing. Our securities fraud litigators are consistently recognized individually as leaders in the field, and our firm is feared and respected by both the defense and the Insurance Board. We pride ourselves on raising billions of dollars for our customers and the…

Source Story here

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...